Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025Open Access

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLauren HarmonZHZachary S. HattigYHYizhou Peter Huang

Discussion

Loading...

Member takes

Overview

Cohort study demonstrates increased germline variant burden in pediatric leukemia, suggesting genetic testing is essential for diagnosis and treatment planning.

Key Points

  • Identified pathogenic germline variants in 5.5% of pediatric AML patients linked to myeloid malignancy.
  • Observed a significant 6.9-fold increase in loss-of-function variants in genes associated with myeloid risk.
  • Applied whole-genome sequencing to a cohort of 365 pediatric AML patients for comprehensive variant analysis.
  • Findings support genetic variant testing as crucial for myeloid malignancies and donor selection for transplants.

Cite This Study

Harmon et al. (2025) studied this question.

synapsesocial.com/papers/689a0c5fe6551bb0af8cf537https://doi.org/10.1101/2025.07.29.25332166
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A high proportion of germline variants in pediatric chronic myeloid leukemia2024 · 10 citations
  2. 2Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition2025
  3. 3Germline predisposition in pediatric malignancies: Insights from a retrospective study at Dana-Farber Cancer Institute2025
  4. 4Pathogenic germline variations and cancer risks in pediatric patients referred for genetic testing2026
  5. 5Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study2024 · 8 citations